Why Germany’s Drug Prices Cause a Trade Showdown with the US

The US is questioning how Germany pays for new medicines. It started an official review under trade rules that let countries challenge unfair pricing. The focus is on whether Germany keeps cutting payments for breakthrough drugs in ways that hurt US companies. Officials worry Germany might speed up